Advanced company searchLink opens in new window

ADAPTATE BIOTHERAPEUTICS LTD

Company number 12166787

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Sep 2024 CS01 Confirmation statement made on 20 August 2024 with no updates
16 Sep 2024 SH19 Statement of capital on 16 September 2024
  • GBP 0.528225
  • ANNOTATION Clarification this form is a second filing of the SH19 registered on 04/09/2023.
29 May 2024 DISS40 Compulsory strike-off action has been discontinued
28 May 2024 GAZ1 First Gazette notice for compulsory strike-off
19 Feb 2024 CH01 Director's details changed for Ms Seyda Atadan Memis on 1 September 2023
04 Sep 2023 SH19 Statement of capital on 4 September 2023
  • GBP 0.528225
  • ANNOTATION Clarification a second filed SH19 was registered on 16/09/2024
04 Sep 2023 SH20 Statement by Directors
04 Sep 2023 CAP-SS Solvency Statement dated 04/09/23
04 Sep 2023 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
  • RES13 ‐ Cancel share prem a/cand capital redemption reserve 04/09/2023
23 Aug 2023 CS01 Confirmation statement made on 20 August 2023 with no updates
26 Jan 2023 TM01 Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
22 Dec 2022 AA Accounts for a small company made up to 31 March 2022
10 Nov 2022 TM01 Termination of appointment of Mark Gibbons as a director on 8 November 2022
26 Aug 2022 CS01 Confirmation statement made on 20 August 2022 with updates
23 Aug 2022 AP01 Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
22 Aug 2022 SH10 Particulars of variation of rights attached to shares
18 Aug 2022 PSC02 Notification of Gammadelta Therapeutics Ltd as a person with significant control on 1 August 2022
18 Aug 2022 PSC07 Cessation of Takeda Pharmaceutical Company Limited as a person with significant control on 1 August 2022
11 Aug 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Company business 01/08/2022
  • RES01 ‐ Resolution of adoption of Articles of Association
11 Aug 2022 MA Memorandum and Articles of Association
10 Aug 2022 MR04 Satisfaction of charge 121667870001 in full
05 May 2022 SH01 Statement of capital following an allotment of shares on 26 April 2022
  • GBP 5,282.262
02 May 2022 PSC05 Change of details for Takeda Pharmaceutical Company Limited as a person with significant control on 26 April 2022
02 May 2022 PSC07 Cessation of Abingworth Llp as a person with significant control on 26 April 2022
29 Apr 2022 AD01 Registered office address changed from Westworks 195 Wood Lane White City Place London W12 7FQ England to 1 Kingdom Street London W2 6BD on 29 April 2022